
---
title: '恒瑞医药：甲磺酸阿帕替尼片临床试验获批'
categories: 
 - 新媒体
 - 36kr
 - 快讯
headimg: 'https://picsum.photos/400/300?random=6198'
author: 36kr
comments: false
date: Tue, 06 Jul 2021 08:49:02 GMT
thumbnail: 'https://picsum.photos/400/300?random=6198'
---

<div>   
36氪获悉，恒瑞医药公告称，甲磺酸阿帕替尼片获得药物临床试验批准通知书；子公司注射用HR20013获得药物临床试验批准通知书。  
</div>
            